ALLIANCE A171601

Primary Category:

Treatment Protocols

Disease Category:

Breast, Breast Metastatic

Status:

New, Open

A Phase II Trial Assessing the Tolerability of Palbociclib in Combination with Letrozole or Fulvestrant in Patients Aged 70 and Older with Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer

NCT#03633331

Eligible for screening study DCP 001